Frontlight ResearchEarly access
Trial site
UCLA Hematology/Oncology - Parkside
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer10 trials
- Triple-negative breast cancer3 trials
- Gastric and oesophageal cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 35 trials
- Phase 24 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Pfizer2 trials
- G1 Therapeutics, Inc.1 trial
- Jazz Pharmaceuticals1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Active, not recruiting
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026